<p>Patients with non-advanced (F0-2) or advanced (F3-4) fibrosis on biopsy were diagnosed by the ELF or ELF/HA model (specificity 80%). True negative and true positive patients identified by both tests are shaded grey; concordant and discordant misclassification rates for the 2 models are shown.</p
<p>LB, liver biopsy; LSM, liver stiffness measurement; kPa, kilopascal.</p><p>A discordance was defi...
Summary Assessment of liver fibrosis is important indetermining prognosis and evaluating interventio...
<p>Mean values of ELF test shown in boxplots for a cohort of patients with and without CSPH each.</p
<p>Misclassification rates were 28.46%, 35.77% and 20.33% in T2W <b>(A)</b>, T1W <b>(B)</b> and EOB-...
Introduction and objectives: A crucial issue when appraising the performance of non-invasive markers...
<p>Serum MMP7 (A), MMP1 (B), AFP (C), HA (D) and the APRI (E) were selected in the optimal linear re...
<p><sup>1</sup>One FibroTest was not reliable, and all AshTest were reliable</p><p>Comparison betwee...
<p><b>Abbreviations</b>: ELF, Enhanced Liver Fibrosis; LSM, liver stiffness measurement; FT, FibroTe...
<p>HA: hyaluronic acid, CI: confidence interval.</p><p>Sensitivity and specificity of different para...
<p>The novel markers of fibrosis were validated alongside the markers for the ELF test, FibroTest, H...
Liver stiffness measurement (LSM) and FibroTest (FT) are frequently used as non-invasive alternative...
International audienceBackgroundNon-invasive tests have been constructed and evaluated mainly for bi...
<p>Diagnostic accuracy (PPV, NPV, Se, Sp) of indirect (Forns, APRI, FIB-4) and direct (ELF) scores (...
Assessment of liver fibrosis is important in determining prognosis and evaluating interventions.Due ...
<p><b>fibrosis stage 3–4 (F3–4).</b> Patients with F3–4 had the significantly higher proportion of d...
<p>LB, liver biopsy; LSM, liver stiffness measurement; kPa, kilopascal.</p><p>A discordance was defi...
Summary Assessment of liver fibrosis is important indetermining prognosis and evaluating interventio...
<p>Mean values of ELF test shown in boxplots for a cohort of patients with and without CSPH each.</p
<p>Misclassification rates were 28.46%, 35.77% and 20.33% in T2W <b>(A)</b>, T1W <b>(B)</b> and EOB-...
Introduction and objectives: A crucial issue when appraising the performance of non-invasive markers...
<p>Serum MMP7 (A), MMP1 (B), AFP (C), HA (D) and the APRI (E) were selected in the optimal linear re...
<p><sup>1</sup>One FibroTest was not reliable, and all AshTest were reliable</p><p>Comparison betwee...
<p><b>Abbreviations</b>: ELF, Enhanced Liver Fibrosis; LSM, liver stiffness measurement; FT, FibroTe...
<p>HA: hyaluronic acid, CI: confidence interval.</p><p>Sensitivity and specificity of different para...
<p>The novel markers of fibrosis were validated alongside the markers for the ELF test, FibroTest, H...
Liver stiffness measurement (LSM) and FibroTest (FT) are frequently used as non-invasive alternative...
International audienceBackgroundNon-invasive tests have been constructed and evaluated mainly for bi...
<p>Diagnostic accuracy (PPV, NPV, Se, Sp) of indirect (Forns, APRI, FIB-4) and direct (ELF) scores (...
Assessment of liver fibrosis is important in determining prognosis and evaluating interventions.Due ...
<p><b>fibrosis stage 3–4 (F3–4).</b> Patients with F3–4 had the significantly higher proportion of d...
<p>LB, liver biopsy; LSM, liver stiffness measurement; kPa, kilopascal.</p><p>A discordance was defi...
Summary Assessment of liver fibrosis is important indetermining prognosis and evaluating interventio...
<p>Mean values of ELF test shown in boxplots for a cohort of patients with and without CSPH each.</p